16741885

Source:http://linkedlifedata.com/resource/pubmed/id/16741885

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012655, umls-concept:C0014834, umls-concept:C0015733, umls-concept:C0017431, umls-concept:C0205216, umls-concept:C0370215, umls-concept:C0733511, umls-concept:C0949665, umls-concept:C1274040, umls-concept:C1880022
pubmed:issue	1
pubmed:dateCreated	2006-6-2
pubmed:abstractText	The prevalence of fecal colonization with Escherichia coli that has reduced susceptibility to fluoroquinolones is unknown. A detailed characterization of such isolates is limited.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/RS1/CCR320627-01, http://linkedlifedata.com/resource/pubmed/grant/U18-HS10399
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16741885-16741876
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0413675
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/DNA Gyrase, http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerase IV, http://linkedlifedata.com/resource/pubmed/chemical/Fluoroquinolones, http://linkedlifedata.com/resource/pubmed/chemical/Nalidixic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Ofloxacin, http://linkedlifedata.com/resource/pubmed/chemical/Solvents
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0022-1899
pubmed:author	pubmed-author:BilkerWarren BWB, pubmed-author:FishmanNeil ONO, pubmed-author:LautenbachEbbingE, pubmed-author:MaoXiangqunX, pubmed-author:MetlayJoshua PJP, pubmed-author:NachamkinIrvingI, pubmed-author:TolomeoPamP
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	194
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	79-85
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:16741885-Anti-Bacterial Agents, pubmed-meshheading:16741885-DNA Gyrase, pubmed-meshheading:16741885-DNA Topoisomerase IV, pubmed-meshheading:16741885-Electrophoresis, Gel, Pulsed-Field, pubmed-meshheading:16741885-Escherichia coli, pubmed-meshheading:16741885-Escherichia coli Infections, pubmed-meshheading:16741885-Feces, pubmed-meshheading:16741885-Fluoroquinolones, pubmed-meshheading:16741885-Genotype, pubmed-meshheading:16741885-Hospitals, pubmed-meshheading:16741885-Humans, pubmed-meshheading:16741885-Microbial Sensitivity Tests, pubmed-meshheading:16741885-Mutation, pubmed-meshheading:16741885-Nalidixic Acid, pubmed-meshheading:16741885-Ofloxacin, pubmed-meshheading:16741885-Phenotype, pubmed-meshheading:16741885-Population Surveillance, pubmed-meshheading:16741885-Solvents
pubmed:year	2006
pubmed:articleTitle	Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
pubmed:affiliation	Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6021, USA. elautenb@cceb.med.upenn.edu
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S.